Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024

BUY
$0.18 - $0.48 $15,920 - $42,454
88,446 Added 142.35%
150,579 $45,000
Q2 2023

Aug 14, 2023

BUY
$0.18 - $0.48 $15,920 - $42,454
88,446 Added 142.35%
150,579 $45,000
Q1 2023

May 14, 2024

SELL
$0.34 - $1.19 $5,081 - $17,784
-14,945 Reduced 19.39%
62,133 $26,000
Q1 2023

May 11, 2023

SELL
$0.34 - $1.19 $5,081 - $17,784
-14,945 Reduced 19.39%
62,133 $26,000
Q4 2022

May 14, 2024

BUY
$1.03 - $2.0 $49,435 - $95,992
47,996 Added 165.04%
77,078 $90,000
Q4 2022

Feb 13, 2023

BUY
$1.03 - $2.0 $49,435 - $95,992
47,996 Added 165.04%
77,078 $90,000
Q3 2022

May 14, 2024

BUY
$0.42 - $3.92 $12,214 - $114,001
29,082 New
29,082 $67,000
Q3 2022

Nov 10, 2022

BUY
$0.42 - $3.92 $12,214 - $114,001
29,082 New
29,082 $0
Q2 2022

Aug 15, 2022

SELL
N/A
-26,807 Closed
0 $0
Q1 2022

May 16, 2022

BUY
N/A
26,807 New
26,807 $258,000

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0

About GreenLight Biosciences Holdings, PBC


  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.